Infectious disease · Phase III

Top sponsors

• United Therapeutics Europe 22 programs
• GSK Glaxo Smith 20 programs
• BRIGHT MINDS BIOSCIENCES 18 programs
• Chinese Academy of 13 programs
• Takeda 12 programs
• Sinovac Research and 11 programs
• Gilead Sciences Ireland 10 programs
• PARItec 10 programs
• Gilead Sciences 9 programs
• Pfizer 8 programs
• Vir Biotechnology 7 programs
• George Institute for 6 programs

1. 1.0% C31G SAVVY vaginal gel

   United Therapeutics Europe Ltd

   HIV Infections

   phase 3 · small molecule · active

   2 trials →

2. 1001

   Biotest Pharma GmbH

   Non-severe community-acquired pneumonia (CAP) or moderate or severe Coronavirus Disease 2019 (COVID-19)

   phase 3 · small molecule · active

   1 trial →

3. 212496

   GlaxoSmithKline

   Respiratory Syncytial Virus Infections

   phase 3 · small molecule · active

   1 trial →

4. 217848

   GlaxoSmithKline

   Respiratory Syncytial Virus Infections

   phase 3 · small molecule · active

   1 trial →

5. 219700

   ViiV Healthcare Pty Ltd

   HIV-1 infection

   phase 3 · small molecule · active

   1 trial →

6. 219816

   ViiV Healthcare Pty Ltd

   Human immunodeficiency virus (HIV)

   phase 3 · small molecule · active

   1 trial →

7. 221611

   ViiV Healthcare Pty Ltd

   HIV Infections

   phase 3 · small molecule · active

   1 trial →

8. 222090

   GlaxoSmithKline

   Respiratory Syncytial Virus Infections

   phase 3 · small molecule · active

   1 trial →

9. 222253

   GlaxoSmithKline

   Respiratory Syncytial Virus Infections

   phase 3 · small molecule · active

   1 trial →

10. ADX-102 Ophthalmic Solution (0.5%)

    Aldeyra Therapeutics

    Non-infectious Anterior Uveitis

    phase 3 · small molecule · completed

    1 trial →

11. AI455-110

    Bristol-Myers Squibb

    HIV Infections

    phase 3 · small molecule · completed

    1 trial →

12. AIN457

    Novartis Pharmaceuticals

    Non-infectious Uveitis

    phase 3 · mab · terminated

    1 trial →

13. ALVAC-HIV vCP1521 + AIDSVAX

    United Therapeutics Europe Ltd

    HIV Infection

    phase 3 · mab · completed

    1 trial →

14. AM-PHN-004

    Amneal Pharma Europe Ltd

    Uncomplicated Urinary Tract Infections

    phase 3 · small molecule · completed

    1 trial →

15. APHP180596

    Pari Pharma GmbH

    antibiotic therapy in Sepsis

    phase 3 · small molecule · active

    1 trial →

16. APHP191099

    Pari Pharma GmbH

    Patients hospitalised in intensive care, diagnosed with sepsis less than 48 hours ago, uric acid level ≥200µmol/L, adults, negative G6PD deficiency

    phase 3 · small molecule · active

    1 trial →

17. APHP191110

    Pari Pharma GmbH

    Patients admitted to the ICU proven or suspected infection as the main diagnosis.

    phase 3 · small molecule · active

    1 trial →

18. APHP200019

    Pari Pharma GmbH

    Patient with sepsis complicated by ARDS

    phase 3 · small molecule · active

    1 trial →

19. APHP210090

    Pari Pharma GmbH

    Adult patients admitted to the ICU for management of severe influenza infection requiring orotracheal intubation for invasive mechanical ventilation

    phase 3 · small molecule · active

    1 trial →

20. APHP211034

    Pari Pharma GmbH

    patients hospitalized in ICU with ESBL-producing Enterobacteriaceae severe infection

    phase 3 · small molecule · active

    1 trial →

21. APHP220763

    Pari Pharma GmbH

    Catheter related bloodstream infections due to Staphylococcus aureus

    phase 3 · small molecule · active

    1 trial →

22. APHP220791

    Pari Pharma GmbH

    CytoMegaloVirus infections, Kidney transplant

    phase 3 · small molecule · active

    1 trial →

23. APHP251262

    Pari Pharma GmbH

    Neisseria gonorrhoeae Infections

    phase 3 · small molecule · active

    1 trial →

24. ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine

    Arcturus Therapeutics Holdings

    COVID-19 Vaccines

    phase 3 · mab · completed

    1 trial →

25. ARCT-2303

    Arcturus Therapeutics Holdings

    COVID-19

    phase 3 · mab · completed

    1 trial →

26. AT-01B-008

    Atea Pharmaceuticals

    Chronic Hepatitis C Virus (HCV) Infection

    phase 3 · small molecule · active

    1 trial →

27. ATM-AVI

    Pfizer

    Complicated Intra-abdominal Infection

    phase 3 · small molecule · completed

    1 trial →

28. ATM-AVI

    Pfizer

    Serious Bacterial Infection

    phase 3 · other · terminated

    1 trial →

29. ATV

    Bristol-Myers Squibb

    HIV Infections

    phase 3 · small molecule · completed

    1 trial →

30. AUTOP 2

    ISTA Pharma Limited

    Bacterial vaginosis, High risk preterm birth pregnancy, Vaginal flora abnormalities

    phase 3 · small molecule · active

    1 trial →

31. AZVUDINE

    The First People's Hospital of Lianyungang

    Chronic Hepatitis B

    phase 3 · small molecule · active

    1 trial →

32. Acyclovir

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 3 · small molecule · completed

    1 trial →

33. Adsorbed COVID-19 (inactivated) Vaccine

    Sinovac Research and Development Co.,

    COVID-19

    phase 3 · mab · completed

    1 trial →

34. Amikacin Inhalation Solution (BAY41-6551)

    Nektar Therapeutics UK Limited

    Pneumonia, Bacterial

    phase 3 · small molecule · completed

    1 trial →

35. Aramchol free acid

    Galmed Pharmaceuticals

    Nonalcoholic Steatohepatitis (NASH)

    phase 3 · small molecule · on hold

    1 trial →

36. Artemether-lumefantrine

    AVENUE THERAPEUTICS, INC.

    Plasmodium Falciparum Malaria

    phase 3 · small molecule · completed

    1 trial →

37. Azithromycin plus hydroxychloroquine

    Iterum Therapeutics plc

    Respiratory Tract Infection Viral

    phase 3 · small molecule · terminated

    1 trial →

38. Azvudine

    Shanghai Henlius Biotech

    SARS-CoV-2 Infection

    phase 3 · small molecule · active

    1 trial →

39. B/F/TAF

    Gilead Sciences Ireland UC

    HIV-1/HBV Co-Infection

    phase 3 · small molecule · completed

    1 trial →

40. B/F/TAF (Adult Strength)

    Gilead Sciences Ireland UC

    HIV-1 Infection

    phase 3 · small molecule · active

    1 trial →

41. BAZOOKA_221

    The George Institute

    Rabies infection/prophylaxis

    phase 3 · small molecule · active

    1 trial →

42. BCG (Tokyo 172) vaccine

    United Therapeutics Europe Ltd

    Tuberculosis Infection

    phase 3 · mab · terminated

    1 trial →

43. BI 201335

    Boehringer Ingelheim

    Hepatitis C, Chronic

    phase 3 · small molecule · completed

    1 trial →

44. BI 201335

    Boehringer Ingelheim

    Hepatitis C

    phase 3 · small molecule · completed

    1 trial →

45. BJT-778

    Blue Earth Diagnostics Ireland Ltd

    Chronic Hepatitis Delta Infection

    phase 3 · small molecule · active

    1 trial →

46. BJT-778

    Blue Earth Diagnostics Ireland Ltd

    Chronic Hepatitis Delta Infection

    phase 3 · small molecule · active

    1 trial →

47. BULEVIRTIDE, BJT-778

    Blue Earth Diagnostics Ireland Ltd

    Chronic Hepatitis D Infection

    phase 3 · small molecule · active

    1 trial →

48. BULEVIRTIDE, BJT-778

    Blue Earth Diagnostics Ireland Ltd

    Chronic Hepatitis D Infection

    phase 3 · small molecule · active

    1 trial →

Frequently asked questions